Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)

Summary

This study was designed to assess the safety and efficacy of GW813893 in the prophylaxis of VTE following TKR and to provide evidence to enable the selection of the appropriate dose(s) and dose regimen of GW813893 for future investigation.

Timeline

Start

2007-02

Primary completion

—

Completion

—

Outcome

Outcome not reported

Stopped: “No longer viable”

Drugs

Indications